Clinical Trials Directory

Trials / Completed

CompletedNCT02912117

Determining the Etiology of Febrile Neutropenia Using the Karius Sequencing-based Infectious Disease Diagnostic Assay

Determining the Etiologic Diagnosis in Febrile Neutropenia Using the Karius Sequencing-based Infectious Disease Diagnostic Assay

Status
Completed
Phase
Study type
Observational
Enrollment
57 (actual)
Sponsor
Karius, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Prospective, observational study at Stanford University Hospital comparing the Karius Infectious Disease Diagnostic Sequencing Assay to the Final Microbiologic Diagnosis in Patients with Fever and Neutropenia.

Conditions

Timeline

Start date
2016-08-01
Primary completion
2018-02-01
Completion
2018-05-01
First posted
2016-09-23
Last updated
2018-05-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02912117. Inclusion in this directory is not an endorsement.